TP53突变和TET2缺陷合作驱动白血病发生并建立免疫抑制环境
Pu Zhang1,2,3, Ethan C Whipp1, Sarah J Skuli4
1Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
The Journal of clinical investigation
|March 20, 2025
概括
在TP53和TET2基因的突变驱动激进的急性髓性白血病 (AML). 向TIGIT可以增强对这些白血病细胞的免疫反应,提供一种新的治疗策略.
科学领域:
- 血液学 血液学 血液学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- TP53突变与髓状瘤的不良预后有关,需要新的治疗方法.
- 突变TP53型白血病代表着一个重要的未满足的临床需求.
- 在急性髓性白血病 (AML) 中,TET2突变经常与TP53突变同时发生.
研究的目的:
- 研究 AML 中结合 TET2 和 TP53 突变的功能后果.
- 确定针对TP53/TET2突变AML的免疫抑制性骨髓微环境的治疗策略.
主要方法:
- 在小鼠模型中血液构造特异性的TET2和TP53删除.
- 对小鼠和人类AML样本的基因表达和免疫细胞群的分析.
- 在临床前模型中评估阻断TIGIT抗体的疗效.
主要成果:
- 在小鼠中,结合TET2/TP53损失导致了可移植AML的自我更新和发展.
- 恶性细胞表现出高调节的先天性免疫信号和增加的CD155表达.
- 丢失TET2/TP53导致扩展的髓质衍生抑制细胞 (MDSCs),损害T细胞功能.
- 在小鼠中,TIGIT阻塞增强了NK细胞活性,减少了瘤负担,并改善了生存率.
结论:
- 在促进白血病方面,TET2和TP53突变之间存在协同作用的联系.
- 异常的NF-κB信号传递和免疫抑制的微环境是这种AML亚型的特征.
- 针对TIGIT的免疫疗法在治疗TP53/TET2突变AML方面表现有前途.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
454
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
454
Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


